Chapter title |
Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases.
|
---|---|
Chapter number | 34 |
Book title |
Amine Oxidases: Function and Dysfunction
|
Published in |
Journal of neural transmission Supplementum, January 1994
|
DOI | 10.1007/978-3-7091-9324-2_34 |
Pubmed ID | |
Book ISBNs |
978-3-21-182521-1, 978-3-70-919324-2
|
Authors |
J. C. Delumeau, D. Bentué-Ferrer, J. M. Gandon, R. Amrein, S. Belliard, H. Allain, Delumeau, J. C., Bentué-Ferrer, D., Gandon, J. M., Amrein, R., Belliard, S., Allain, H. |
Abstract |
Recent data obtained in animals and in humans suggest that both MAO-A and MAO-B inhibitors present cognitive enhancing properties of possible interest in the treatment of cognitive disorders. In addition, the rational for using selegiline as a neuroprotector in Parkinson's disease may also be applicable in Alzheimer's disease in which a dramatic increase in the MAO-B activity has been reported. It seems then worthwhile to investigate the neuroprotective effect of MAOIs in humans and to assess, furthermore, the real therapeutical benefit of their cognitive enhancing properties. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 4% |
Unknown | 22 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 22% |
Student > Master | 4 | 17% |
Student > Bachelor | 3 | 13% |
Researcher | 2 | 9% |
Student > Doctoral Student | 1 | 4% |
Other | 5 | 22% |
Unknown | 3 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 22% |
Neuroscience | 4 | 17% |
Psychology | 4 | 17% |
Chemistry | 2 | 9% |
Biochemistry, Genetics and Molecular Biology | 2 | 9% |
Other | 4 | 17% |
Unknown | 2 | 9% |